Impaired lung homeostasis in neonatal mice exposed to cigarette smoke

Sharon McGrath-Morrow1, Tirumalai Rangasamy, Cecilia Cho

  • 1Department of Pediatrics, Division of Pediatric Pulmonary, Johns Hopkins Hospital, Park 316/600 N. Wolfe St., Baltimore, MD 21287-2533, USA. smorrow@jhmi.edu

Insights

Neonatal exposure to cigarette smoke (CS) harms infant lung development. This study found CS exposure in newborn mice suppressed immune genes and impaired lung growth, potentially explaining increased respiratory issues in children.

Area of Science:

  • Pulmonary Medicine
  • Immunology
  • Developmental Biology

Background:

  • Infant smoke exposure correlates with respiratory illnesses and reduced lung function.
  • The perinatal period is a critical window for lung development, potentially increasing susceptibility to environmental toxins like cigarette smoke (CS).

Purpose of the Study:

  • To investigate the effects of neonatal cigarette smoke (CS) exposure on lung immunity and growth in mice.
  • To determine if perinatal CS exposure alters immune gene expression and lung development.

Main Methods:

  • Neonatal mice were exposed to CS for 14 days.
  • Pulmonary gene expression profiling, immunohistochemistry (Nitrotyrosine, TUNEL, MAC3, p-SMAD2), and lung volume measurements were performed.

Main Results:

  • CS exposure significantly inhibited type 1 and type 2 interferon pathway genes in neonatal lungs.
  • Increased Nitrotyrosine, TUNEL, and p-SMAD2 staining observed in neonatal CS-exposed lungs.
  • CS exposure during the neonatal period led to modestly decreased lung volumes at 8 weeks, indicating impaired lung growth.

Conclusions:

  • Neonatal CS exposure suppresses innate immune gene expression in the developing lung.
  • Perinatal CS exposure results in mild impairment of postnatal lung growth.
  • These findings may explain the higher incidence of respiratory symptoms in infants exposed to CS.